[Immunotherapy of breast cancer (review of foreign literature)].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology; D001500:BCG Vaccine / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000276:immunology; D007167:Immunotherapy; D007978:Levamisole / Q000627:therapeutic use; D008207:Lymphatic Metastasis / Q000628:therapy; D010956:Plasmapheresis; D011425:Propionibacterium acnes / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D014859:Warfarin / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; D007136:Immunoglobulins; D007978:Levamisole; D014859:Warfarin
Immunoterapiia raka molochnoĭ zhelezy (obzor inostrannoĭ literatury).